Personnel Information

写真a

NISHIDA Yoichiro


Job title

Associate Professor

Graduating School 【 display / non-display

  • Tokyo Medical and Dental University, Graduated

Graduate School 【 display / non-display

  • Tokyo Medical and Dental University, Doctor's Course, Completed

Campus Career 【 display / non-display

  • 2014.04
    -
    2016.07
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Neurology and Neurological Science, Assistant Professor
  • 2014.04
    -
    2019.10
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Department of Neurology, Neurosurgery,Psychiatry and Anesthesiology, Neurology, Assistant Professor
  • 2016.07
    -
    2017.03
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Department of Neurology, Neurosurgery,Psychiatry and Anesthesiology, Neurology, Junior Associate Professor
  • 2016.07
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Neurology and Neurological Science, Junior Associate Professor
  • 2017.04
    -
    2019.10
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Department of Neurology, Neurosurgery,Psychiatry and Anesthesiology, Neurology, Junior Associate Professor
  • 2019.11
    -
    2020.01
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Department of Neurology, Neurosurgery,Psychiatry and Anesthesiology, Neurology, Junior Associate Professor
  • 2020.02
    -
    2020.03
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Department of Neurology, Neurosurgery,Psychiatry and Anesthesiology, Neurology, Junior Associate Professor
  • 2020.04
    -
    2021.04
    Tokyo Medical and Dental University, (Old Organization)Medical Hospital, Hospital Departments, Department of Neurology, Neurosurgery,Psychiatry and Anesthesiology, Neurology, Junior Associate Professor
  • 2021.05
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Neurology and Neurological Science, Associate Professor
  • 2021.05
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Neurology and Neurological Science, Associate Professor

▼display all

Qualification Acquired 【 display / non-display

  • Doctor

 

Published Papers & Misc 【 display / non-display

  1. Ethan A Winkler, Yoichiro Nishida, Abhay P Sagare, Sanket V Rege, Robert D Bell, David Perlmutter, Jesse D Sengillo, Sara Hillman, Pan Kong, Amy R Nelson, John S Sullivan, Zhen Zhao, Herbert J Meiselman, Rosalinda B Wenby, Jamie Soto, E Dale Abel, Jacob Makshanoff, Edward Zuniga, Darryl C De Vivo, Berislav V Zlokovic. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat. Neurosci.. 2015.04; 18 (4): 521-530. ( PubMed, DOI )

  2. Okamoto T, Ishizuka T, Shimizu R, Asahina Y, Nakamura H, Shimizu Y, Nishida Y, Yokota T, Lin Y, Sato W, Yamamura T. Efficacy and Safety of the Natural Killer T Cell-Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical Trial. JMIR research protocols. 2024.01; 13 e46709. ( PubMed, DOI )

  3. Yokote H, Miyazaki Y, Toru S, Nishida Y, Hattori T, Niino M, Sanjo N, Yokota T. High-efficacy therapy reduces subcortical grey matter volume loss in Japanese patients with relapse-onset multiple sclerosis: A 2-year cohort study. Multiple sclerosis and related disorders. 2022.11; 67 104077. ( PubMed, DOI )

  4. Tamaki Kana, Nishida Yoichiro, Sanjo Nobuo, Yokota Takanori. 早期速効性治療により惹起されたクリーゼ兆候を有する全身型重症筋無力症患者(A patient with generalized myasthenia gravis facing an impending crisis triggered by early fast-acting treatment) Clinical and Experimental Neuroimmunology. 2022.05; 13 (2): 99-101. ( ichushi )

  5. Yamada Akane, Nishida Yoichiro, Wake Kenjiro, Nakamura Ayako, Sakamaki Yuriko, Kuwahara Hiroya, Uchihara Toshiki, Yokota Takanori. Serial ultrathin sections to identify ultrastructural localization of GLUT1 molecules in vesicles in brain endothelial cells-correlative light and electron microscopy in depth(和訳中) Microscopy. 2022.04; 71 (2): 124-131. ( ichushi )

  6. Yamada A, Nishida Y, Wake K, Nakamura A, Sakamaki Y, Kuwahara H, Uchihara T, Yokota T. Serial ultrathin sections to identify ultrastructural localization of GLUT1 molecules in vesicles in brain endothelial cells-correlative light and electron microscopy in depth. Microscopy (Oxford, England). 2022.04; 71 (2): 124-131. ( PubMed, DOI )

  7. Nishida Y, Ishiguro T, Yokota T. Tap-Elicited Clonus of the Biceps and Triceps Brachii. JAMA neurology. 2022.02; 79 (2): 194. ( PubMed, DOI )

  8. Shinya Akiko, Takahashi Makoto, Sato Nozomu, Nishida Yoichiro, Inaba Akira, Inaji Motoki, Yokota Takanori, Orimo Satoshi. 髄腔内バクロフェン療法が成功した痙性不全対麻痺として現れた眼・歯・指異形成症(Oculo-dento-digital Dysplasia Presenting as Spastic Paraparesis Which Was Successfully Treated by Intrathecal Baclofen Therapy) Internal Medicine. 2021.07; 60 (14): 2301-2305. ( ichushi )

  9. Yoichiro Nishida, Takanori Yokota. Reversible Reduction of Dopamine Transporter Uptake in a Case of Hydrocephalus. Annals of neurology. 2021.05; ( PubMed, DOI )

  10. Akiko Shinya, Makoto Takahashi, Nozomu Sato  Yoichiro Nishida, Akira Inaba, Motoki Inaji, Takanori Yokota, Satoshi Orimo . A Case of Oculo-dento-digital Dysplasia Presenting as Spastic Paraparesis Which Was Successfully Treated by Intrathecal Baclofen Therapy. Internal medicine (Tokyo, Japan). 2021.02; ( PubMed, DOI )

  11. Hiroaki Yokote, Shuta Toru, Yoichiro Nishida, Takaaki Hattori ,Nobuo Sanjo, Takanori Yokota. Serum amyloid A level correlates with T2 lesion volume and cortical volume in patients with multiple sclerosis. Journal of neuroimmunology. 2021.02; 351 577466. ( PubMed, DOI )

  12. Mitsuru Watanabe, Yuri Nakamura, Shinya Sato, Masaaki Niino, Hikoaki Fukaura, Masami Tanaka, Hirofumi Ochi, Takashi Kanda, Yukio Takeshita, Takanori Yokota, Yoichiro Nishida, Makoto Matsui, Shigemi Nagayama, Susumu Kusunoki, Katsuichi Miyamoto, Masanori Mizuno, Izumi Kawachi, Etsuji Saji, Takashi Ohashi, Shun Shimohama, Shin Hisahara, Kazutoshi Nishiyama, Takahiro Iizuka, Yuji Nakatsuji, Tatsusada Okuno, Kazuhide Ochi, Akio Suzumura, Ken Yamamoto, Yuji Kawano, Shoji Tsuji, Makoto Hirata, Ryuichi Sakate, Tomonori Kimura, Yuko Shimizu, Akiko Nagaishi, Kazumasa Okada, Fumie Hayashi, Ayako Sakoda, Katsuhisa Masaki, Koji Shinoda, Noriko Isobe, Takuya Matsushita, Jun-Ichi Kira . HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data. Scientific reports. 2021.01; 11 (1): 607. ( PubMed, DOI )

  13. Sugita Y, Nishida Y, Ishibashi S, Yokota T. Convexity Subarachnoid Hemorrhage Soon after Starting a Direct Oral Anticoagulant in 2 Patients with Acute Infarction. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2020.11; 29 (11): 105216. ( PubMed, DOI )

  14. Yanagidaira M, Nishida Y, Yokota T. Temporal correlation between serum CH<sub>50</sub> level and symptom severity of myasthenia gravis during eculizumab therapy. Clinical neurology and neurosurgery. 2020.02; 189 105630. ( PubMed, DOI )

  15. Yokote Hiroaki, Amano Ryota, Toru Shuta, Hattori Takaaki, Nishida Yoichiro, Sanjo Nobuo, Yokota Takanori. 多発性硬化症患者における血清アミロイドA蛋白の上昇と脳萎縮との関連(Brain atrophy is associated with higher serum amyloid A levels in patients with multiple sclerosis) 臨床神経学. 2019.11; 59 (Suppl.): S400. ( ichushi )

  16. Amano Akiko, Sanjo Nobuo, Nakakido Makoto, Tsumoto Kouhei, Matsubara Etsuro, Furukawa Fumiko, Nishida Yoichiro, Saito Takashi, Saido Takaomi, Yokota Takanori. ドットブロット法を用いたマウス脳におけるAβオリゴマーの定量的評価(Quantitative evaluation of Aβ oligomer in mouse brain using dot blot method) Dementia Japan. 2019.10; 33 (4): 515. ( ichushi )

  17. Nishida Y, Takahashi YK, Kanai T, Nose Y, Ishibashi S, Sanjo N, Uzawa A, Oda F, Ozawa Y, Kuwabara S, Noguchi E, Suzuki S, Nakahara J, Suzuki N, Ogawa T, Yokoyama K, Hattori N, Konno S, Fujioka T, Kawaguchi N, Hatanaka Y, Sonoo M, Kaneko J, Ogino M, Nishiyama K, Nomura K, Yokota T. Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis. European journal of neurology. 2019.07; ( PubMed, DOI )

  18. Guo L, Bertola DR, Takanohashi A, Saito A, Segawa Y, Yokota T, Ishibashi S, Nishida Y, Yamamoto GL, Franco JFDS, Honjo RS, Kim CA, Musso CM, Timmons M, Pizzino A, Taft RJ, Lajoie B, Knight MA, Fischbeck KH, Singleton AB, Ferreira CR, Wang Z, Yan L, Garbern JY, Simsek-Kiper PO, Ohashi H, Robey PG, Boyde A, Matsumoto N, Miyake N, Spranger J, Schiffmann R, Vanderver A, Nishimura G, Passos-Bueno MRDS, Simons C, Ishikawa K, Ikegawa S. Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation. American journal of human genetics. 2019.05; 104 (5): 925-935. ( PubMed, DOI )

  19. Nishida Yoichiro, Hizume Masaki, Fumimura Yuichi, Ichikawa Tadashi. ドネペジルにより改善した小脳性認知情動症候群(Cerebellar Cognitive Affective Syndrome Improved by Donepezil) Internal Medicine. 2019.04; 58 (7): 1003-1006. ( ichushi )

  20. Takahashi Yuko K., Nishida Yoichiro, Nose Yurie, Ishibashi Satoru, Sanjo Nobuo, Kanai Tetsuya, Uzawa Akiyuki, Oda Fumiko, Ozawa Yukiko, Kuwabara Satoshi, Yokota Takanori. Calcineurin Inhibitors Can Be Safely Reduced in Most Patients with Well-controlled Myasthenia Gravis NEUROLOGY. 2019.04; 92 (15):

  21. Takahashi K, Yanai S, Takisawa S, Kono N, Arai H, Nishida Y, Yokota T, Endo S, Ishigami A. Vitamin C and vitamin E double-deficiency increased neuroinflammation and impaired conditioned fear memory. Archives of biochemistry and biophysics. 2019.03; 663 120-128. ( PubMed, DOI )

  22. Yokote H., Amano R., Toru S., Hattori T., Nishida Y., Sanjo N., Yokota T.. Brain Atrophy is Associated with Higher Serum Amyloid A Levels in Patients with Relapsing and Remitting Multiple Sclerosis and Clinically Isolated Syndrome MULTIPLE SCLEROSIS JOURNAL. 2019.03; 25 (3): 442.

  23. Nishida Y, Hizume M, Fumimura Y, Ichikawa T. Cerebellar Cognitive Affective Syndrome Improved by Donepezil. Internal medicine (Tokyo, Japan). 2018.12; ( PubMed, DOI )

  24. Miura M, Numasawa Y, Takahisa M, Ozaki K, Irioka T, Nishida Y, Ishibashi S, Yokota T. Levodopa-responsive truncal tremor in a patient with spinocerebellar ataxia type 3. Journal of the neurological sciences. 2018.09; 392 32-33. ( PubMed, DOI )

  25. Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S, Japanese Eculizumab Trial for GBS (JET-GBS) Study Group.. Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial. The Lancet. Neurology. 2018.06; 17 (6): 519-529. ( PubMed, DOI )

  26. Yamada A., Numasawa Y., Hattori T., Ozaki K., Ishibashi S., Nishida Y., Kanouchi T., Sanjo N., Takanori Y.. Signal changes of skeletal muscle MRI in peripheral nerve disorders JOURNAL OF THE NEUROLOGICAL SCIENCES. 2017.10; 381 1068. ( DOI )

  27. Nishida Y., Winkler E., Sagare A., De Vivo D., Zlokovic B.. Decreased glucose transporter 1 expression at the blood-brain barrier exacerbates Alzheimer disease-like phenotypes in mouse models JOURNAL OF THE NEUROLOGICAL SCIENCES. 2017.10; 381 768. ( DOI )

  28. Nobuko Yamaguchi, Sonoko Misawa, Yasunori Sato, Kengo Nagashima, Kanako Katayama, Yukari Sekiguchi, Yuta Iwai, Hiroshi Amino, Tomoki Suichi, Takanori Yokota, Yoichiro Nishida, Nobuo Kohara, Koichi Hirata, Kazutoshi Nishiyama, Ichiro Yabe, Ken-Ichi Kaida, Norihiro Suzuki, Hiroyuki Nodera, Shoji Tsuji, Haruki Koike, Jun-Ichi Kira, Hideki Hanaoka, Susumu Kusunoki, Satoshi Kuwabara, . A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS). JMIR Res Protoc. 2016.11; 5 (4): e210. ( PubMed, DOI )

  29. Daishi Yui, Yoichiro Nishida, Tomoko Nishina, Kaoru Mogushi, Mio Tajiri, Satoru Ishibashi, Itsuki Ajioka, Kinya Ishikawa, Hidehiro Mizusawa, Shigeo Murayama, Takanori Yokota. Enhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading Enzyme. PLoS ONE. 2015; 10 (12): e0143518. ( PubMed, DOI )

  30. Yoichiro Nishida, Akihiko Ueda, Yukio Ando, Tadashi Ichikawa. Skin Biopsy-based Diagnosis of CADASIL with Atypical MRI Findings. Intern. Med.. 2015; 54 (5): 537-538. ( PubMed, DOI )

  31. Kazuo Iwasa, Keisuke Shima, Kiyonobu Komai, Yoichiro Nishida, Takanori Yokota, Masahito Yamada. Retinitis pigmentosa and macular degeneration in a patient with ataxia with isolated vitamin E deficiency with a novel c.717 del C mutation in the TTPA gene. J. Neurol. Sci.. 2014.10; 345 (1-2): 228-230. ( PubMed, DOI )

  32. Abhay P Sagare, Robert D Bell, Alaka Srivastava, Jesse D Sengillo, Itender Singh, Yoichiro Nishida, Nienwen Chow, Berislav V Zlokovic. A lipoprotein receptor cluster IV mutant preferentially binds amyloid-β and regulates its clearance from the mouse brain. J. Biol. Chem.. 2013.05; 288 (21): 15154-15166. ( PubMed, DOI )

  33. Teruhiko Sekiguchi, Hiroyuki Tomimitsu, Teruhiko Sekiguchi, Yoichiro Nishida, Takashi Irioka, Akira Inaba, Yoshinobu Hoshii. ATTR amyloidosis complicated by phrenic nerve palsy. Can J Neurol Sci. 2013.01; 40 (1): 129-130. ( PubMed )

  34. Teruhiko Sekiguchi, Yoichiro Nishida, Akira Inaba, Shigeo Toyota. Mesothelioma-mimicking multiple myeloma with dumbbell-type progression. Intern. Med.. 2013; 52 (11): 1287-1288. ( PubMed )

  35. Yoichiro Nishida, Tadashi Ichikawa. Pontine hyperperfusion during recovery from central pontine myelinolysis. Intern. Med.. 2012; 51 (7): 817-818. ( PubMed )

  36. Yoichiro Nishida, Takashi Irioka, Teruhiko Sekiguchi, Hidehiro Mizusawa. Pure sensory infarct in the territories of anterior cerebral artery. Neurology. 2010.07; 75 (3): 287. ( PubMed, DOI )

  37. Yoichiro Nishida, Shingo Ito, Sumio Ohtsuki, Naoki Yamamoto, Tsubura Takahashi, Nobuhisa Iwata, Kou-Ichi Jishage, Hiromi Yamada, Hiroki Sasaguri, Shigefumi Yokota, Wenying Piao, Hiroyuki Tomimitsu, Takaomi C Saido, Katsuhiko Yanagisawa, Tetsuya Terasaki, Hidehiro Mizusawa, Takanori Yokota. Depletion of vitamin E increases amyloid beta accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease. J. Biol. Chem.. 2009.11; 284 (48): 33400-33408. ( PubMed, DOI )

  38. Yoichiro Nishida, Yuki Saito, Takanori Yokota, Takashi Kanda, Hidehiro Mizusawa. Skeletal muscle MRI in complex regional pain syndrome. Intern. Med.. 2009; 48 (4): 209-212. ( PubMed )

  39. Yoichiro Nishida, Hiroshi Komachi, Hidehiro Mizusawa. A case of Listeria meningitis associated with increased adenosine deaminase in cerebrospinal fluid. Diagn. Microbiol. Infect. Dis.. 2007.04; 57 (4): 435-437. ( PubMed, DOI )

  40. Yoichiro Nishida, Takanori Yokota, Tsubura Takahashi, Toshiki Uchihara, Kou-ichi Jishage, Hidehiro Mizusawa. Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochem. Biophys. Res. Commun.. 2006.11; 350 (3): 530-536. ( PubMed, DOI )

  41. Yong-Ri Ren, Yoichiro Nishida, Kenji Yoshimi, Toru Yasuda, Kou-Ichi Jishage, Toshiki Uchihara, Takanori Yokota, Yoshikuni Mizuno, Hideki Mochizuki. Genetic vitamin E deficiency does not affect MPTP susceptibility in the mouse brain. J. Neurochem.. 2006.09; 98 (6): 1810-1816. ( PubMed, DOI )

  42. Y Nishida, N Sodeyama, Y Toru, S Toru, T Kitamoto, H Mizusawa. Creutzfeldt-Jakob disease with a novel insertion and codon 219 Lys/Lys polymorphism in PRNP. Neurology. 2004.11; 63 (10): 1978-1979. ( PubMed )

  43. Sumio Ishiai, Yasumasa Koyama, Naomi Nakano, Keiko Seki, Yoichiro Nishida, Kazuko Hayashi. Image of a line is not shrunk but neglected. Absence of crossover in unilateral spatial neglect. Neuropsychologia. 2004; 42 (2): 251-256. ( PubMed )

  44. Y Nishida, M Yamada, K Hara, T Tsunemi, M Yamawaki, R Shimokawa, R Okeda, T Tsutsumi, H Mizusawa. Creutzfeldt-Jakob disease after Jannetta's operation with cadaveric dura mater graft: initial manifestations related to the grafted site. J. Neurol.. 2002.04; 249 (4): 480-483. ( PubMed, DOI )

▼display all

Conference Activities & Talks 【 display / non-display

  1. Yokote Hiroaki, Miyazaki Yusei, Toru Shuta, Nishida Yoichiro, Hattori Takaaki, Niino Masaaki, Sanjo Nobuo, Yokota Takanori. 日本人多発性硬化症患者の脳容積減少を抑制する有効性の高い治療法(High-efficacy therapy reduces brain volume loss in Japanese patients with multiple sclerosis). 臨床神経学 2023.09.01

  2. Okamoto Tomoko, Sato Wakiro, Lin Youwei, Shimizu Yuko, Nishida Yoichiro, Yokota Takanori, Ishizuka Takami, Nakamura Harumasa, Takahashi Yuji, Yamamura Takashi. 糖脂質OCH-NCNP1 多発性硬化症患者を対象とした第II相臨床試験プロトコール(Glycolipid OCH-NCNP1: Protocol of Phase II Clinical Trial for Patients with Multiple Sclerosis). 臨床神経学 2022.10.01

  3. Yokote Hiroaki, Toru Shuta, Nishida Yoichiro, Hattori Takaaki, Sanjo Nobuo, Yokota Takanori. 多発性硬化症患者の血清アミロイドAタンパク質値と皮質容積の関連性(Association between serum amyloid A and cortical volume in patients with multiple sclerosis). 臨床神経学 2020.11.01